Tristel Share Discussion Threads

[paulisi] 22/2/2021 07:46

Numbers were a bit lower than expected, but still loads of potential in growth

[best1467] 22/2/2021 07:24

Was slightly worried for these numbers but extremely pleased with 15% in the circumstances.
India looks to be very close So overall should underpin the valuation and plenty of growth looking forward with the Pandemic beginning to decline

[piedro] 18/2/2021 12:07

Something for the jitters ...

Ecolab Dips 4.1% As COVID-19 Dented 4Q Profit
Amit Singh
Feb 17, 2021, 8:46 AM
"Shares of Ecolab dropped 4.1% on Tuesday, after the company, which provides water, hygiene, and energy technologies and services, reported lower-than-expected 4Q results, primarily due to the COVID-19 pandemic. ... ..."


LOL &
GLA :-)

[thewheeliedealer] 17/2/2021 21:34

Hi everyone,

My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast last week and part of our discussion includes a TopSlice of the position I hold in TSTL and my thinking behind this. I still like it a lot and am holding a fair chunk of my Portfolio but it had just grown too big, relative to my other Stocks.

As always we also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. We also start off with quite a bit about the overall Markets and where they are most likely heading.

Anyway, if you use Youtube, Apple, Audioboom, Overcast, Google+ or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 42) and you can find it on Soundcloud at the link below.

I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !!

Cheers, WD
@wheeliedealer

[mach100] 16/2/2021 20:51

Buying Opportunity. We know results will be good on Monday and may see some positioning on Friday ahead of results. Inida is a a bit of a puzzle as it should have been complete by end of last year but perhaps Covid has ironically slowed it down. Would be a nice accompanyment to results. Only a note of caution on hospital disinfectant sales would hurt TSTL on Monday. Maybe a special divi though as the company is throwing off cash?

[apad] 16/2/2021 16:14

0.35% dilution since before Xmas doesn't help!

Beginning of Feb. it was on the 50SMA, which is where it is now, so not that big a drop.

I wonder if option shares are on the MMs books? Just speculation, beyond my experience.

I'm still hoping for a BTFD opportunity on results morning.

apad

[q2u] 16/2/2021 15:41

It has a habit of dropping suddenly on low volume that can make trading very profitable. I missed the boat this time having pointed out that it was a bit overvalued but got too greedy.
the company rarely lets shareholders down so don't worry.

[portugull] 16/2/2021 14:16

Big drop today 66p 9.8%. No news?

[football] 15/2/2021 11:28

Don't think they get a blanket FDA approval as Byotrol from memory had to get for each state it was sold in

[anley] 15/2/2021 10:26

If that is the case then the company will have to wait its turn............

[glaws2] 12/2/2021 10:23

The problem with the US market is two fold; firstly, it can't get its staff over here to finish it's trials and secondly, and this is pure supposition, the FDA approval must be being slowed by the huge amount of Covid drugs that need to be approved.

[apad] 11/2/2021 19:06

First bought in 2014 at about 80p anley. Thanks for the reassurance 😊
Nevertheless, there might well be some disappointment after the results.
BTFD?
apad

[anley] 11/2/2021 18:45

APAD........this is an international business not just a UK one. As and when it gets itself in to the US market with a good sales company and that is to be seen to work by the markets and as the other areas of the world expand then the price could be a great deal higher.

Forget the IC and brokers reports this company does not need that publicity. There arn't enough shares for anyone to get a really big holding so keep what you have.

[hpcg] 10/2/2021 23:50

I have to say the IC has improved immensely in the last 6 months. It seems to have a better grasp of what works and has ditched some of the tired old tropes that the financial industry has used to prey on investors.

[apad] 10/2/2021 17:00

Back in the day the IC was one of few sources of investment information, Zimbtrader. It has been totally eclipsed and the likes of ST has to produce yards of text on a regular basis to sell the paper.
I'm no good at trading in and out. FWIW I think you'll get an opportunity after the next results. Hospitals are still bloody empty and that's where their high margin business lies.

apad

[zimbtrader] 10/2/2021 16:25

Good comments, APAD. Not saying I won't return. Out been out completely once before and came back in at 422 a year ago (if memory serves).I guess we all form judgements based on our experience and our personal levels of comfort with an investment. I felt there were better opportunities elsewhere.PS. I gave up on IC a long time back. Got some good tips from ST but some absolute dogs as well!

[apad] 10/2/2021 10:12

Interesting to hear, Zimbtrader.
"this can only be the market pricing in US approval and roll out at scale. Looks very overvalued otherwise"
The presumption here is that there is a fair value metric for all companies and a rational pricing by the market that accounts for future possibilities.
TSTL is a £300million company with about 150 employees that has a significant niche in a mass market and a specialist market. It is expanding worldwide in different ways.
I don't think there is a way of valuing such companies, in the conventional sense.
The TSTL story has been pretty much the same since we both bought our first shares.
The price movement has been something of a popularity rating, as evidenced by your IC observation.
As long as the story hasn't changed I expect there to be some pessimistic observations that depress the price in the future that may give me an opportunity to increase. The price/popularity is riding high at the moment.
Value judgements from a pessimistic perspective by commentators have been a powerful help to my stock picking.
That pessimism always rules over optimism is written in our genes.
Telling me that bears hide behind that bush gets my immediate attention and acceptance. Tell me about the safe route to avoid bears and I'm only half listening.
BOO/FEVR/BVXP/TSTL are 70% of my portfolio and the 'overvalued' mantra has been a constant background hum for all four shares. Their gains are 405%/351%/103%/239%.
I increase my holdings all the time, so I bought BOO last July at £2.
apad

[hpcg] 10/2/2021 10:00

I bought in June and sold yesterday. Might be a mistake, or might just be an opportunity to reenter at a lower price, very difficult to tell. I don't think the growth matches the return I made for 7-8 months holding. I do have other places to put the money. A look back at the chart indicates holding has been the perfect tactic, as obviously it must at ATH.

[zimbtrader] 10/2/2021 09:44

Guess I got this one wrong when I exited back in November after being a holder since 2014! I am very surprised at the level now and think this can only be the market pricing in US approval and roll out at scale. Looks very overvalued otherwise but, hey, got it wrong before! And right, to be fair; I doubled up when ST made them a sell in 2015 (if memory serves) at 120p.Well done those that hung in and fingers crossed for you with looming result's.

[melody9999] 09/2/2021 21:40

I'm looking for TSTL to emulate the ERGO share price action!

[apad] 09/2/2021 16:52

Interesting to compare different styles.
I bought 19 times between May & July last year at an average price of £4.71.
My previous purchases were between 2014 and 2017.
Last year did seem to be oversold, with idiot tintin comments about overpriced.
For me it is a commitment hold unless the story changes and the danish, disposable endoscopes take over the world.
GLA
apad

[q2u] 09/2/2021 14:08

I keep selling small(ish) parcels into this rise. I can't help feeling it is getting a bit ahead of itself and is overvalued on current figures, and even with the update to come, but it keeps going up. I have held these for 8 years and it is my best performer by some way so there is no way I am selling up completely. There is a lot more to come in future years I feel.

[piedro] 09/2/2021 14:03

A'ternoon Mach.

With a sound boat I prefer to ride out the storms.

GLA

[mach100] 09/2/2021 13:52

Afternoon Piedro. I expect a boom up to results unless that boom has already occurred to date. I sold some last time as a hedge at 514p and they only continued to rise. If they retain the current trajectory I will again sell some because although the rise is infectious I don't want to catch a cold on any drop.

[piedro] 09/2/2021 10:32

Also, I expect more of a boardroom shake out:

RNS Number : 7255I
Tristel PLC
15 December 2020

Result of AGM
Tristel plc (AIM:TSTL), the manufacturer of infection prevention products, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

Where a resolution received approval by a majority of less than 80% of the votes cast, the Board has sought to understand the reasons behind the against votes and take appropriate action if considered necessary.

David Orr, who is a non-independent Director and whose re-election was passed under Resolution 7, is a member of both the Audit and Remuneration committees to the Board. Having heard shareholders' views and in order to comply with UK best practice recommendations for a Company of Tristel's size, David will step down from these two Board committees.

Resolution 12, which concerns the 2021 Executive Management Share Option Plan, was also duly passed. It is the Board's understanding that shareholders who have voted against the resolution have done so with respect to two features of the scheme. The first is that no overall dilution limit has been disclosed, the second is that a proportion of the awards under the plan vest subject to absolute share price growth targets.

In recognition of the first point, the Board undertakes to disclose dilution limits for participants in future Executive Management plans. With respect to the second point, the Board concludes, following consultation, that there is not a universally held view amongst institutional shareholders regarding share price growth targets. A counter view, widely expressed, is that a share price performance measure aligns Management to all shareholders' interests and provides very clear targets.

The AGM Results may be seen here ...